CMA
52
2
AIG
66
4
ZBH
48
-2
ORCL
68
3
CI
49
3
RCL
62
-3
LRCX
55
-6
FSLR
76
3
QRVO
34
-4
HAL
50
4
REGN
65
2
HBI
62
7
SNA
60
2
LMT
52
2
MAS
51
-11
FLS
75
8
XOM
54
3
PEG
55
2
AMGN
55
-2
CF
44
-3
CMA
52
2
AIG
66
4
ZBH
48
-2
ORCL
68
3
CI
49
3
RCL
62
-3
LRCX
55
-6
FSLR
76
3
QRVO
34
-4
HAL
50
4
REGN
65
2
HBI
62
7
SNA
60
2
LMT
52
2
MAS
51
-11
FLS
75
8
XOM
54
3
PEG
55
2
AMGN
55
-2
CF
44
-3
Financhill
Back

EyePoint Pharmaceuticals Stock Predictions

Sell
50

EYPT
EyePoint Pharmaceuticals

Last Price:
11.83
Seasonality Move:
6.87%

7 Day Trial

ALL ACCESS PASS

$ 7

EyePoint Pharmaceuticals Stock Forecast

  • Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically fallen by 1.3% based on the past 19 years of stock performance.
  • EyePoint Pharmaceuticals has fallen lower in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%
  • Is EyePoint Pharmaceuticals Stock Undervalued?
    The current EyePoint Pharmaceuticals [EYPT] share price is $11.84. The Score for EYPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • EYPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will EyePoint Pharmaceuticals Stock Go Up Next Year?

  • Over the next 52 weeks, EyePoint Pharmaceuticals has on average historically fallen by 1.3% based on the past 19 years of stock performance.

EyePoint Pharmaceuticals Stock Rating

Sell
50
EyePoint Pharmaceuticals (EYPT) is a Sell

Is EyePoint Pharmaceuticals overpriced?

  • EyePoint Pharmaceuticals has fallen lower in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%

EyePoint Pharmaceuticals Stock Price History

Is EYPT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
eyepointpharma.com

52-Week Data

52-Week High:
30.99
52-Week Low:
5.67

Prediction Charts

Market Cap:
616.68M
Price in USD:
11.84
Volume:
1.04M
Beta:
1.99

Technical Analysis

SMA50:
18.80
SMA100:
22.13
SMA200:
16.41
52-Wk Change:
84.71%

Stock Predictions

  • Is EyePoint Pharmaceuticals stock public?
    Yes, EyePoint Pharmaceuticals is a publicly traded company.
  • What is the EyePoint Pharmaceuticals stock quote today?
    The EyePoint Pharmaceuticals stock price is 11.84 USD today.
  • How to buy EyePoint Pharmaceuticals stock online?
    You can buy EyePoint Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 17.42 17.60 18.04 16.94
May-1 17.72 18.04 18.81 17.43
May-2 18.48 19.93 20.32 17.83
May-3 20.30 19.74 21.26 19.71
May-6 13.89 11.15 14.00 11.06
May-7 11.20 11.87 11.89 10.65
May-8 11.87 11.56 12.30 11.38
May-9 12.34 12.67 12.95 11.75
May-10 12.80 12.09 12.90 11.97
May-13 12.20 12.22 12.51 11.94
May-14 12.49 12.45 12.96 12.34
May-15 12.71 12.94 13.42 12.68
May-16 12.90 12.52 13.04 12.27
May-17 12.49 11.84 12.49 11.81

EyePoint Pharmaceuticals Earnings

EyePoint Pharmaceuticals Earnings Report: Per Share EyePoint Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

EyePoint Pharmaceuticals Forecast Revenue Growth

EyePoint Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for EyePoint Pharmaceuticals and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.85 per share.

* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.